Physician

Mandeep Singh Dhalla, MD

According to 2025 Medicare claims, Mandeep Dhalla, MD (NPI: 1457389447) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33308-1909.

Dhalla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 831 traditional Medicare patients, billed 16,897 HCPCS/CPT codes, and received $2,206,323 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 136 prescription claims across 56 beneficiaries totaling $32,478 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 6 records totaling $155. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $219,421 to $32,478. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.3M2015 Medicare payment: $2,827,769 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,170,448 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,162,763 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,321,802 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,276,351 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,648,888 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,558,970 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,647,202 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,573,203 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,206,323 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201593113,278$2,827,769
201694814,839$3,170,448
201795015,017$3,162,763
20181,00215,931$3,321,802
201998416,563$3,276,351
202085113,620$2,648,888
202193213,372$2,558,970
202293211,838$2,647,202
202392712,819$2,573,203
202483116,897$2,206,323

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$110K$219K2015 Drug cost: $219,421 (USD; Tot_Drug_Cst)2016 Drug cost: $87,011 (USD; Tot_Drug_Cst)2017 Drug cost: $28,329 (USD; Tot_Drug_Cst)2018 Drug cost: $31,530 (USD; Tot_Drug_Cst)2019 Drug cost: $24,424 (USD; Tot_Drug_Cst)2020 Drug cost: $17,716 (USD; Tot_Drug_Cst)2021 Drug cost: $15,641 (USD; Tot_Drug_Cst)2022 Drug cost: $27,742 (USD; Tot_Drug_Cst)2023 Drug cost: $42,677 (USD; Tot_Drug_Cst)2024 Drug cost: $32,478 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015123442$219,421
2016115386$87,011
201794326$28,329
2018100341$31,530
201993334$24,424
202099295$17,716
202183274$15,641
202278244$27,742
202361140$42,677
202456136$32,478

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1551,832$653
67028Injection of drug into eye2541,174$110
92014Established patient complete exam of visual system7161,190$95
92012Established patient problem focused exam of visual system193257$73
92134Imaging of retina7581,954$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate24669$2,962
Prednisolone AcetatePrednisolone Acetate351,568$1,577
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat271,722$285
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim11452$90

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$155ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mandeep Singh Dhalla, MD?

Tedicare shows public-source Medicare data for Mandeep Singh Dhalla, MD (NPI 1457389447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mandeep Singh Dhalla, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mandeep Singh Dhalla, MD?

Mandeep Singh Dhalla, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Mandeep Singh Dhalla, MD have Open Payments data?

Mandeep Singh Dhalla, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.